Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/3880 stock hub

HKG/3880 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/3880is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/3880

In the news

Latest news · HKG/3880

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.4

P25 11.7P50 18.9P75 41.4

Trailing P/E12

P25 10.7P50 17.9P75 38.5

ROE22.8

P25 -14.7P50 2P75 9.4

ROIC33.8

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/3880 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

CNY

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	566
Enterprise value	HKD 1.9B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100006S86
Last refreshed	2026-05-10
Market cap	HKD 3.1B
Price	HKD 21.82
Price currency	HKD
Rev Per Employee	1,120,845.68x
Sector	Healthcare
Sic	8731
Symbol	hkg/3880
Website	https://www.medtideinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.82%
EV Earnings	7.99x
EV/EBIT	8.23x
EV/EBITDA	7.25x
EV/FCF	12.49x
EV/Sales	3.05x
FCF yield	5%
Forward P/E	10.41x
P/B ratio	1.75x
P/E ratio	12.04x
P/S ratio	4.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	37.01%
EBITDA Margin	41.74%
FCF margin	24.39%
Gross margin	63.43%
Gross Profit	HKD 402.4M
Gross Profit Growth	21.95%
Gross Profit Growth Q	45.16%
Gross Profit Growth3 Y	21.65%
Gross Profit Growth5 Y	17.61%
Net Income	HKD 241.9M
Net Income Growth	267.35%
Net Income Growth Q	1,240.6%
Net Income Growth3 Y	42.3%
Net Income Growth5 Y	22.05%
Pretax Margin	43.98%
Profit Margin	38.13%
Profit Per Employee	HKD 427,372
ROA	8.84
ROCE	13.03
ROE	22.84
ROIC	33.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	332.1
EPS Growth Q	1,077.4
EPS Growth3 Y	47.78
EPS Growth5 Y	9.01
FCF Growth	39.74%
FCF Growth3 Y	20.52%
FCF Growth5 Y	7.58%
OCF Growth	121.93%
OCF Growth Q	8.4%
OCF Growth3 Y	34.25%
OCF Growth5 Y	14.38%
Revenue Growth	28.91x
Revenue Growth Q	29.23x
Revenue Growth3 Y	15.36x
Revenue Growth5 Y	15.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.38
Assets	HKD 2B
Cash	HKD 1.2B
Current Assets	HKD 1.4B
Current Liabilities	HKD 222.2M
Debt	HKD 34.2M
Debt EBITDA	HKD 0.13
Debt Equity	HKD 0.02
Debt FCF	HKD 0.22
Equity	HKD 1.8B
Interest Coverage	170.6
Liabilities	HKD 253.5M
Long Term Assets	HKD 594.3M
Long Term Liabilities	HKD 31.3M
Net Cash	HKD 1.2B
Net Cash By Market Cap	HKD 37.55
Net Cash Growth	113.47%
Net Debt EBITDA	HKD -4.39
Net Debt Equity	HKD -0.66
Net Debt FCF	HKD -7.51
Tangible Book Value	HKD 1.6B
Tangible Book Value Per Share	HKD 11.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.4
Inventory Turnover	2.22
Net Working Capital	HKD -2.1M
Quick ratio	5.77
Working Capital	HKD 1.2B
Working Capital Turnover	HKD 0.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	28.83
50-day SMA	22.59
50-day SMA vs 200-day SMA	50under200
All Time High	41.72
All Time High Change	-47.7%
All Time High Date	2025-08-21
All Time Low	21.04
All Time Low Change	3.71%
All Time Low Date	2026-03-27
ATR	0.75
Beta1y	0.98
Ch YTD	-28.41
High	22.2
High52	41.72
High52 Date	2025-08-21
High52ch	-47.7%
Low	21.46
Low52	21.04
Low52 Date	2026-03-27
Low52ch	3.71%
Ma50ch	-3.4%
Price vs 200-day SMA	-24.32%
RSI	45.77
RSI Monthly	0
RSI Weekly	32.98
Sharpe ratio	-0.78x
Sortino ratio	-1.03
Total Return	-3.96%
Tr YTD	-28.41
Tr1m	-1.45%
Tr1w	-1%
Tr3m	-9.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 234.8M
Operating Income Growth	41.94
Operating Income Growth Q	94.17
Operating Income Growth3 Y	37.21
Operating Income Growth5 Y	20.34
Operating margin	37.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	22,171,750%
Net Borrowing	-12,026,924.5
Shares Insiders	69.3%
Shares Institutions	3.79%
Shares Out	141,800,000
Shares Qo Q	13.62%
Shares Yo Y	3.96%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 149.6M
Average Volume	103,335x
Bv Per Share	12.44
CAPEX	HKD -142.9M
Ch1m	-1.45
Ch1w	-1
Ch3m	-9.46
Ch6m	-28.69
Change	-0.18%
Change From Open	-0.09
Close	21.86
Days Gap	-0.09
Depreciation Amortization	31,053,049.2
Dollar Volume	2,192,910
Earnings Date	2026-05-29
EBIT	HKD 234.8M
EBITDA	HKD 264.8M
EPS	HKD 1.81
F Score	7
FCF	HKD 154.7M
FCF EV Yield	8.01x
FCF Per Share	HKD 1.09
Financing CF	468,753,512
Fiscal Year End	December
Founded	2,020
Goodwill	109,866,024.5
Graham Number	22.51624
Graham Upside	3.19
Income Tax	HKD 37.1M
Investing CF	-192,991,343
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Lynch Fair Value	HKD 39.94
Lynch Upside	83.04
Ma150	26.86
Ma150ch	-18.78%
Ma20	21.95
Ma20ch	-0.58%
Net CF	556,920,355
Next Earnings Date	2026-05-29
Open	21.84
P FCF Ratio	20
P OCF Ratio	10.4
Position In Range	48.65
Ppne	461,203,305.2
Price Date	2026-05-08
Price EBITDA	HKD 11.68
Ptbv Ratio	1.91
Relative Volume	0.97x
Revenue	634,398,656x
SBC By Revenue	0.81x
Share Based Comp	5,143,409
Tax By Revenue	5.85x
Tax Rate	13.31%
Tr6m	-28.69%
Volume	100,500
Z Score	12.45

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/3880 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/3880?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.8%

Share of float held by funds and institutions

Insider ownership

+69.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.0%

Negative means the company is buying back shares.

Technical

HKG/3880 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.8

Neutral momentum band

Price vs 200-day MA

-24.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/3880

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/3880 stock rating?

hkg/3880 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/3880 analysis?

The full report lives at /stocks/hkg/3880/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/3880?

The latest report frames hkg/3880 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/3880 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.